Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 6, Pages 10944-10957
Publisher
MDPI AG
Online
2013-05-25
DOI
10.3390/ijms140610944
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The many faces and functions of β-catenin
- (2012) Tomas Valenta et al. EMBO JOURNAL
- Second-line systemic therapy for the treatment of metastatic renal cell cancer
- (2012) Stephan Kruck et al. Expert Review of Anticancer Therapy
- WNT10A Plays an Oncogenic Role in Renal Cell Carcinoma by Activating WNT/β-catenin Pathway
- (2012) Ren-Jun Hsu et al. PLoS One
- Expression and Clinical Significance of Von Hippel-Lindau Downstream Genes: Jade-1 and β-Catenin Related to Renal Cell Carcinoma
- (2012) Xin Lian et al. UROLOGY
- High cytoplasmic expression of p27Kip1 is associated with a worse cancer-specific survival in clear cell renal cell carcinoma
- (2011) Stephan Kruck et al. BJU INTERNATIONAL
- Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma
- (2011) Koji Ueno et al. MOLECULAR CARCINOGENESIS
- HIF-2 Enhances -Catenin/TCF-Driven Transcription by Interacting with -Catenin
- (2010) H. Choi et al. CANCER RESEARCH
- The Role of Wnt/Beta-Catenin Signaling in Renal Carcinogenesis: Lessons from Cadmium Toxicity Studies
- (2010) F. Thevenod et al. CURRENT MOLECULAR MEDICINE
- Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma
- (2010) Hiroshi Hirata et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma
- (2010) Hanna Ronkainen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Altered modulation of WNT–β-catenin and PI3K/Akt pathways in IgA nephropathy
- (2010) Sharon N. Cox et al. KIDNEY INTERNATIONAL
- Oncogenic Functions of Secreted Frizzled-Related Protein 2 in Human Renal Cancer
- (2010) S. Yamamura et al. MOLECULAR CANCER THERAPEUTICS
- Functional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer
- (2009) K. Kawakami et al. CANCER RESEARCH
- Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3
- (2009) Sonja Röhrs et al. CELL BIOLOGY INTERNATIONAL
- Inhibition of Vascular Endothelial Growth Factor Receptor-1/Wnt/ -catenin Crosstalk Leads to Tumor Cell Death
- (2009) B. D. Zeitlin et al. CLINICAL CANCER RESEARCH
- Wnt Antagonist Gene DKK2 Is Epigenetically Silenced and Inhibits Renal Cancer Progression through Apoptotic and Cell Cycle Pathways
- (2009) H. Hirata et al. CLINICAL CANCER RESEARCH
- Interplay of Cadherin-Mediated Cell Adhesion and Canonical Wnt Signaling
- (2009) J. Heuberger et al. Cold Spring Harbor Perspectives in Biology
- Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling
- (2008) Su-Li Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now